Insulin secretion
Showing 1 - 25 of 9,960
Metabolic Syndrome Trial in Guadalajara (Celery Seed, Placebo)
Recruiting
- Metabolic Syndrome
- Celery Seed
- Placebo
-
Guadalajara, Jalisco, MexicoINSTITUTO DE TERAPÉUTICA EXPERIMENTAL Y CLÍNICA. Centro Universi
Sep 25, 2023
Hypercholesterolemia, Insulin Resistance, Insulin Secretion Trial in Tuebingen (Lowering cholesterol concentrations by PCSK-9
Recruiting
- Hypercholesterolemia
- +2 more
- Lowering cholesterol concentrations by PCSK-9 inhibitor
-
Tuebingen, GermanyUniversity of Tuebingen, Department of Internal Medicine IV
Aug 24, 2022
Spinal Cord Stimulation, Insulin Secretion Trial in Tuebingen (BurstDR stimulation, Tonic stimulation, No stimulation)
Recruiting
- Spinal Cord Stimulation
- Insulin Secretion
- BurstDR stimulation
- +2 more
-
Tuebingen, GermanyUniversity Hospital Tuebingen
Apr 3, 2023
PreDiabetes, Impaired Glucose Tolerance, Hyperglycemia Trial in Guadalajara (Probiotics, Metformin)
Active, not recruiting
- PreDiabetes
- +3 more
- Probiotics
- Metformin
-
Guadalajara, Jalisco, MexicoINSTITUTO DE TERAPÉUTICA EXPERIMENTAL Y CLÍNICA. Centro Universi
Jan 8, 2023
ELAPOR1 or ELAPOR2 on Insulin Secretion and Glucose Regulation
Not yet recruiting
- Type 2 Diabetes
- Impaired Insulin Secretion
-
Tübingen, GermanyUniversity Hopsital Tübingen
Oct 11, 2022
Metabolic Disease Trial in Boston (Hyperglycemic Clamp, Kisspeptin-10, Placebo)
Recruiting
- Metabolic Disease
- Hyperglycemic Clamp
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Jul 12, 2022
Insulin, Glucose, Healthy Volunteers Trial in Boston (Kisspeptin-10, mixed meal tolerance test)
Recruiting
- Insulin
- +4 more
- Kisspeptin-10
- mixed meal tolerance test
-
Boston, MassachusettsMassachusetts General Hospital
Jul 19, 2022
Type1 Diabetes Trial in Paris (Low carbohydrate diet)
Not yet recruiting
- Type1 Diabetes
- Low carbohydrate diet
-
Paris, FranceAP-HP - Pitié-Salpêtrière Hospital
Sep 7, 2022
Prediabetes, Impaired Fasting Glucose, Impaired Glucose Tolerance Trial in Guadalajara (Berberine, Metformin)
Active, not recruiting
- Prediabetes
- +2 more
- Berberine
- Metformin
-
Guadalajara, Jalisco, MexicoInstituto de Terapeútica Experimental y Clínica. Centro Universi
Jun 2, 2022
Pre-Diabetic Trial in Rochester (Calcitriol capsules, Oral Placebo)
Terminated
- Pre-Diabetic
- Calcitriol capsules
- Oral Placebo
-
Rochester, MinnesotaMayo Clinic
Feb 17, 2022
Healthy Volunteers Trial in Baltimore (Nabllone, CP-945,598, Hypoglycemic Clamp)
Completed
- Healthy Volunteers
- Nabilone
- +3 more
-
Baltimore, MarylandNational Institute of Aging, Clinical Research Unit
Jan 18, 2023
Type 1 Diabetes Trial in Vancouver (Frexalimab, Placebo, Insulin)
Recruiting
- Type 1 Diabetes Mellitus
- Frexalimab
- +2 more
-
Vancouver, British Columbia, CanadaInvestigational Site Number : 1240001
Oct 31, 2023
Diabetes Trial in Lancaster (Zinc acetate)
Completed
- Diabetes
- Zinc acetate
-
Lancaster, PennsylvaniaAmish Research Clinic
Jan 4, 2022
Type 2 Diabetes Trial in Birmingham (Low Glycemic Diet, Control Diet)
Recruiting
- Type 2 Diabetes Mellitus
- Low Glycemic Diet
- Control Diet
-
Birmingham, AlabamaThe University of Alabama at Birmingham
Apr 6, 2022
Defining Decline in Endogenous Insulin Secretion in Type 1
Recruiting
- Diabetes Mellitus, Type 1
- Progression
-
Exeter, Devon, United KingdomRoyal Devon & Exeter NHS Foundation Trust
Feb 24, 2022
Dietary Nitrate Supplementation Trial in Singapore (Beetroot juice)
Recruiting
- Dietary Nitrate Supplementation
- Beetroot juice
-
Singapore, SingaporeSingapore Institute for Clinical Sciences
Oct 11, 2022
Insulin Secretion Trial in Vellore (Ferrous sulphate)
Completed
- Insulin Secretion
- Ferrous sulphate
-
Vellore, Tamil Nadu, IndiaChristian Medical College
Feb 11, 2022
Cystic Fibrosis, Pancreatic Insufficiency, Abnormal Glucose Tolerance Trial in Philadelphia (Dulaglutide 0.75Mg/0.5Ml Inj Pen)
Recruiting
- Cystic Fibrosis
- +3 more
- Dulaglutide 0.75Mg/0.5Ml Inj Pen
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jan 11, 2023
Insulin Secretion Trial in Durham (GIP infusion, GLP-1 infusion, Ex-9 infusion)
Suspended
- Insulin Secretion
- GIP infusion
- +2 more
-
Durham, North CarolinaDuke Center for Living
Sep 12, 2022
PreDiabetes, Diabetes type2, Intermittent Fasting Trial in Germany (Intermittent fasting, Control diet)
Recruiting
- PreDiabetes
- +3 more
- Intermittent fasting
- Control diet
-
Berlin, Germany
- +7 more
Dec 8, 2021
Type 2 Diabetes Trial in Sha Tin (Biogenetic explanation and endocrinologist intensive managment, Usual care management)
Active, not recruiting
- Type 2 Diabetes
- Biogenetic explanation and endocrinologist intensive managment
- Usual care management
-
Sha Tin, Hong KongThe Chinese University of Hong Kong
Jul 19, 2022
Type2 Diabetes Trial in Duesseldorf (AP-325, Placebo matching AP-325)
Recruiting
- Type2 Diabetes
- AP-325
- Placebo matching AP-325
-
Duesseldorf, NRW, GermanyGerman Diabetes Center
Jan 5, 2022
Diabetes Type 2 in Obese, Inflammation, Metabolic Disease Trial in Basel (Anakinra Prefilled Syringe)
Recruiting
- Diabetes Mellitus Type 2 in Obese
- +3 more
- Anakinra Prefilled Syringe
-
Basel, Basel BS, SwitzerlandUniversity Hospital Basel
Sep 7, 2021
Cystic Fibrosis, Pancreatic Insufficiency Trial in Philadelphia (Sitagliptin, Placebo)
Completed
- Cystic Fibrosis
- Pancreatic Insufficiency
- Sitagliptin
- Placebo
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia and University of Pennsylvan
Feb 24, 2022